Cerner Announces Next Evolution of Cerner Millennium®

CernerCerner (Nasdaq: CERN) announced the launch of Millennium+™, the next evolution of Cerner Millennium®. Combining the enterprise platform with the secure Cerner Cloud, Millennium+ delivers a new user experience that is fast, smart and easy. It provides personalized, intuitive and relevant clinical workflows via the desktop, tablet and smartphone.

Cerner understands the importance of health system and community interoperability, which is why Millennium+ integrates and unifies information gathered within the organization and across the community into a provider's workflow. Millennium+ is designed to speed up workflows, reduce clicks and ensure Cerner solutions provide each user the information they need at the right point in the workflow in context of the person, condition and venue.

In addition to Sepsis alerting and Chart Search, one of the first solutions that will be launched as part of the Millennium+ platform is PowerChart+Touch™. PowerChart+Touch was created specifically for the iPad. With a swipe of a finger, providers can quickly and easily navigate workflows. As part of the Millennium+ platform, solutions are available on-demand versus relying on major release schedules to access to new capabilities. This provides client organizations, departments and individual users to more quickly adapt to new capabilities, regulatory mandates and quality measurements.

"Cerner is going beyond foundational automation of the health record and creating a new experience; not just a repository to chart activity or place orders," said Jeff Townsend, Cerner chief of staff and executive VP. "With this new combination of capabilities, Cerner is well positioned to accelerate innovation around the second order effects of a digitized industry. What you can do now with Millennium+ is much more than just being paperless, it moves the boundaries beyond a typical Enterprise Health Record system."

Millennium+ creates a new user experience that is:

Fast

  • Millennium+ is designed for optimal performance. The solution speeds up access to comprehensive clinical workflows, anticipating the data requirements to complete end-to-end experiences while reducing clicks and improving context of care.

Smart

  • Millennium+ is smart and aware of the context of the patient, the location and the user. It anticipates "next," and brings information face up in the context of the next decision or action, making it moment relevant.

Easy

  • Millennium+ is easy to use. The interaction is intuitive, with minimal training and configuration required.

Millennium+ solutions are currently rolling out to physicians through the end of the year and to additional providers through 2013.

About Cerner
Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we’ve learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.

Cerner® solutions are licensed by approximately 9,300 facilities around the world, including more than 2,650 hospitals; 3,750 physician practices; 40,000 physicians; 500 ambulatory facilities, such as laboratories, ambulatory centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 40 employer sites and 1,600 retail pharmacies.

Certain trademarks, service marks and logos (collectively, the "Marks") set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. All other non-Cerner Marks are the property of their respective owners. Nasdaq: CERN.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...